retatrutide triple agonist gip glp-1 glucagon Calling a “GLP-3” is usually a quick sign that you don't understand the underlying biology. Retatrutide is a NuSH-based agonist—it targets GLP-1, GIP, and receptors. Only one of those Retatrutide Research Peptide | COA

Others cycle it (e.g., 12 weeks on, 4 weeks off) or use it strategically during periods when metabolic support is needed (fat loss phases, aging, etc.)

Stimulates the use of free fatty acids for energy production

Abstract Sulfur containing amino acids contribute substantially to the maintenance and integrity of cellular systems by influencing cellular redox state and cellular capacity to detoxify toxic compounds, free radicals and reactive oxygen species

The Fund may have significant exposure to biotechnology companies in connection with its investments in GLP-1 & Weight Loss Companies

have a history of urinary tract infections or problems with urination